Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kengo Azushima

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|March 25, 2017
ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in MiceKohji Ohki, Hiromichi Wakui, Kengo Azushima, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 7, 2012
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patientsTomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, et al.
Kidney International Reports|September 19, 2022
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis PatientsDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Scientific Reports|January 14, 2021
Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney diseaseSho Kinguchi, Hiromichi Wakui, Yuzuru Ito, et al.
Kidney International|January 14, 2017
An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease modelRyu Kobayashi, Hiromichi Wakui, Kengo Azushima, et al.
Journal of the American Heart Association|April 13, 2019
Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent HypertensionSho Kinguchi, Hiromichi Wakui, Kengo Azushima, et al.
Journal of the American Heart Association|March 21, 2015
Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevationHiromichi Wakui, Kazushi Uneda, Kouichi Tamura, et al.
Kidney International|March 3, 2022
Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarizationKotaro Haruhara, Toru Suzuki, Hiromichi Wakui, et al.
Journal of Atherosclerosis and Thrombosis|April 3, 2024
Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD StudyEiko Ueda, Kohei Ishiga, Hiromichi Wakui, et al.
Clinical and Experimental Nephrology|June 25, 2022
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in JapanDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|March 25, 2017
ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in MiceKohji Ohki, Hiromichi Wakui, Kengo Azushima, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 7, 2012
Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patientsTomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, et al.
Kidney International Reports|September 19, 2022
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis PatientsDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Scientific Reports|January 14, 2021
Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney diseaseSho Kinguchi, Hiromichi Wakui, Yuzuru Ito, et al.
Kidney International|January 14, 2017
An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease modelRyu Kobayashi, Hiromichi Wakui, Kengo Azushima, et al.
Journal of the American Heart Association|April 13, 2019
Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent HypertensionSho Kinguchi, Hiromichi Wakui, Kengo Azushima, et al.
Journal of the American Heart Association|March 21, 2015
Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevationHiromichi Wakui, Kazushi Uneda, Kouichi Tamura, et al.
Kidney International|March 3, 2022
Deficiency of the kidney tubular angiotensin II type1 receptor-associated protein ATRAP exacerbates streptozotocin-induced diabetic glomerular injury via reducing protective macrophage polarizationKotaro Haruhara, Toru Suzuki, Hiromichi Wakui, et al.
Journal of Atherosclerosis and Thrombosis|April 3, 2024
Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD StudyEiko Ueda, Kohei Ishiga, Hiromichi Wakui, et al.
Clinical and Experimental Nephrology|June 25, 2022
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in JapanDaisuke Kanai, Hiromichi Wakui, Tatsuya Haze, et al.
Pageof 11